Sign in
4

Changes in Ownership

Raphael Pharmaceutical Inc. Filed Acc 0001213900-23-019557

Options or other derivatives

  • Chief Executive Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pilo Shlomo Chief Executive Officer 2022-12-05 Grant or award · Warrants to Purchase Common Stock +1,000,000 1,000,000 D
Loading xslF345X03/ownership.xml…